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Chromosome Aberrations as a Measure
of Mutagenesis:
Comparisons in Vitro and in Vivo and in
Somatic and Germ CeIIs*
by i. 6. Brewent and R. I. Prestont
Structural alterations to chromosomes con-
stitute a significant portion of the genetic
damage produced by most mutagenic agents.
The pioneering experiments of Muller (1),
in the case of ionizing radiations, and of
Auerbach (2), in the case of nitrogen mus-
tards, showed that chromosome aberrations
are, quantitatively, a significant class of mut-
ational events for both physical and chem-
ical mutagens.
The ultimate goal in any mutagen screen-
ing program is to be able to test potential
mutagens directly on human genetic material
or to extrapolate to man from other test
systems with confidence. At present the
easiest way to attain that goal is to use
chromosomal aberrations as an index of mut-
ational damage. It is quite simple to obtain
a large number of homogeneous human cells,
treat them with the agent in question, ana-
lyze the chromosomes at the subsequent
mitosis, and, if desired, compare the results
to identical studies done on other mammalian
species.
The technique employed in this instance
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is short-term tissue culture of peripheral
leukocytes (3). The procedure is technically
simple, but it presents particular uncer-
tainties and difficulties in interpreting the
data. The experiments on human cells must
be done in vitro, and the question arises as
to whether the response is quantitatively and
qualitatively the same as that in vivo. Second,
the experiments are done on somatic cells,
and the effect on the genetically important
germ cells may be quite different. Third, even
if the experiments are done on laboratory
animals, where the germ eclls can be treated
in vivo, the problem of differential cell stage
sensitivity (4,5) and interspecific variations
in sensitivity (6) must be accounted for.
The present paper is addressed to those
problems. The majority of the data are de-
rived from experiments utilizing low-LET
radiations as the mutagenic agent, although
some data are presented from studies of
chemical mutagens.
Comparisons of Aberration Production
in Vivo and in Vitro
The most extensive quantitative data on
the production of damage to human genetic
material have come from studies on the
induction of chromosome aberrations in peri-
December 1973 157pheral leukocytes by ionizing radiations.
With a few notable exceptions of accidental
and therapeutic exposures, the data have
been derived from in vitro experimentation.
McFee et al. (7) first compared in vivo
and in vitro production of chromosomal
aberrations by ionizing radiation in their
study on swine leukocytes irradiated with
14-MeV neutrons. Their data showed a
significant difference in the quantitative
yield, depending upon whether the exposure
was given in vivo or in vitro. The data, how-
ever, are difficult to interpret because of
dosimetric problems arising from tissue
shielding and dose attenuation. The authors
made calculations to account for these dif-
ficulties (7), but the in vivo doses carry a
large standard error due to blood distribu-
tion through the body. Subsequent to that
study, we conducted extensive comparisons
of aberration production in vivo and in
vitro by low-LET radiations in peripheral
leukocytes of three mammalian species:
Mus muscutlus (6), Cricetulus griseu-s (8),
and Saguinus fuscicollis (9). All three
species are small, so the problem of dose
attenuation was minimal. The results of those
experiments are summarized in Table 1.
The data lead us to conclude that when the
cells receive comparable doses of ionizing
radiation the chromosome damage sustained
is quantitatively and qualitatively the same
in vivo and in vitro.
The problems encountered in making sim-
ilar comparisons for chemical mutagens are
considerably more complex. First, adminis-
tration of equivalent doses on a weight-
volume basis to the target cells is very diffi-
cult. Second, if it is assumed that equivalent
doses are administered to the target cells, con-
sideration must be given to the fact that
for in vitro testing the cells are directly ex-
posed to the compound, whereas in in vivo
testing the compound is being carried to the
target cells by the circulatory system and
must cross the blood-tissue barrier. Third,
the compound may be detoxified in vivo by
tissues other than the target cells. And
fourth, some metabolites of the compound
may be mutagenic themselves. These prob-
lems make the in vitro testing of compounds
for in vivo extrapolation virtually impossible.
There are several examples where the
above problems are manifested in experi-
mental testing. Brock and Hohorst (10)
have shown that cyclophosphamide induces
chromosomal aberrations in vivo but not in
vitro. The work of Schmid et al. (11) and
Arakaki and Schmid (12) shows that, to
produce equivalent degrees of chromosome
damage in Chinese hamster bone marrow
cells treated in vivo and Chinese hamster
fibroblast cells treated in vitro, the dose of
Trenimon administered in vivo has to be 100
times higher than the dose in vitro. The data
of Arakaki and Schmid (12) also show that
the amount of damage depends on the cell
type used in the in vitro experiments.
We have done similar experiments with an
alkylating agent. Human leukocytes were
Table 1. Frequencies of centric rings plus dicentrics observed in the peripheral
leukocytes of M. musculus, C. griseus, and S. fisciollis
after in vivo and in vitro irradiation.
Frequency, %
M. musculus C. griseus S. fuscicollis'
Dose, R In vivo In vitro In vivo Invitro In vivo In vitro
0 0.0 0.3 + 0.3 0.0 0.0 0.0 0.0
50 4.3 ± 1.2 2.3 0.9 2.7 ± 1.0 3.5 ± 1.1
100 7.3 ± 1.6 6.7 ± 1.5 7.0 ± 1.5 8.0 ± 1.6 13.7 ± 1.2 13.3 ± 2.1
200 19.7 ± 2.6 14.3 ± 2.2 18.6 ± 2.3 21.0 ± 2.7 40.0 ± 2.1 33.3 ± 3.3
300 27.4 ± 4.3 31.3 ± 3.2 38.0 ± 3.6 70.7 ± 4.9 68.7 ± 4.8
400 51.7 ± 4.2 65.0 ± 8.0 63.3 ± 4.6 94.4 ± 6.1 98.3 ± 5.7
a Irradiation was with
I Co -y-rays at a dose rate of 3.7 R/min.
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either in vitro or in a simulated in vivo en-
vironment consisting of diffusion chambers
implanted in mice (13). The mice were in-
jected either intraperitoneally or intraven-
ously with 130 mg/kg of MMS 12 or 24 hr
before the diffusion chambers were removed
and the human leukocytes were prepared for
chromosome analysis. The in vitro regimen
consisted of treating short-term cultures of
peripheral leukocytes with 1.2 x 10-4M
(0.013 mg/ml) MMS for 2 hr beginning 6,
12, or 18 hr before the cultures were fixed
for chromosome analysis. The in vitro dose
was thus only 1/10 the in vivo dose. The
cells were also pulse-labeled with tritiated
thymidine so that cells replicating their DNA
at the onset of the in vitro exposure could
be distinguished from those that were not.
The results of the experiment are sum-
marized in Table 2. Since there was no sig-
nificant difference in the data for the 6- and
12-hr treatments in the in vitro experiment,
or between intravenous and intraperitoneal
administration of the MMS in the in vivo
experiment, these respective groups are
pooled in Table 2. The data indicate two
things: (1) cells replicating their DNA are
approximately five times as sensitive as
cells in G, or G2, and (2) there is an "ap-
parent" difference of one to two orders of
magnitude between the in vivo and in vitro
sensitivities. The quantitative difference be-
tween the in vivo and in vitro responses is
difficult to interpret. It may reflect a failure
of the MMS to penetrate the Millipore filter
used in constructing the diffusion cham-
bers, detoxification by the host animal, or
inadequate sample size of sensitive (i.e., S-
stage) cells examined in each instance; or
it may indicate a true difference in response
by the same cell type under two different
sets of conditions. It is obvious, however,
that the problems presented to the study of
mutagenesis by chemicals are much more
complex than those encountered in radiation
studies.
Interspecific Comparisons
Before quantitative data derived in muta-
genesis testing on laboratory animals can
be used to make meaningful predictive
statements concerning man, a "bridge" of
information is needed between the two spe-
cies. At present, chromosome aberration
studies appear to offer the greatest possi-
bility for establishing that "bridge", simply
because there is already a great deal of in-
formation and because the current tech-
niques lend themselves to rapid accumula-
tion of large amounts of data.
We have recently finished an interspecific
comparison of the radio-sensitivities of the
peripheral leukocytes of several mammalian
species (6). In those experiments we irrad-
iated freshly drawn blood, or the animal
under study, with x-rays or y-rays at a high
dose rate. The leukocytes were then cul-
tured in various ways, and the resulting
first mitotic divisions were analyzed for
chromosome-type aberrations. The aberra-
tion types analyzed were asymmetrical in-
terchanges (dicentrics), asymmetrical in-
Table 2. Frequencies of various types of chromatid aberrations in MMS-treated human leukocytes.
No. cells Deletions, % Exchanges, %
Time, hr scored L, % b U, % b L U L U
In vitro
6,12 390 33.8 66.2 33.3 5.8 1.5 0
18 168 54.0 46.0 84.6 13.0 117.6 7.8
In vivo
12 600 7.0 ± 1.1 2.7 ± 0.7
24 700 4.4 ± 0.8 2.0 ± 0.5
a The time corresponds to the time before fixation that MMS was added.
L = labeled, U = unlabeled.
December 1973 159terarm intrachanges (centric rings), and
acentric fragments. Dose-response curves
were made, and relative yields of dicentrics
and acentric fragments presumed to be de-
letions were compared among species. Sev-
eral facts were found. The yields of dicen-
trics increased exponentially with dose for
all species (Fig. 1). Although the yields of
deletions were relatively constant among
species, the yields of dicentrics were higher
in the species with higher chromosome arm
numbers. The relationship of dicentrics and
chromosome arm number was such that a
linear fit to the equation, Y = (N - 1) (bD +
c1D2) where N equals the "effective" arm
number, was falrly good at each dose (Fig.
2). This indicates that the probability of pro-
ducing an interchange is directly propor-
tional to chromosome arm number, pro-
vided DNA content is kept constant. Thus
we conclude that man is twice as sensitive
as the mouse to the production of inter-
changes by ionizing radiation. Since there
is preliminary evidence (14,15) that dicen-
tric yields are indicative of the genetically
important reciprocal translocations (sym-
metrical interchanges), it seems reasonable
to assume that translocation yields ob-
served in the mouse are approximately one-
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FIGURE 1. Best-estimate regression curves for dicen-
tric production in six mammalian species.
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FIGURE 2. Best-estimate regression curves for dicen-
tric yields vs. chromosome arm number in six
mammalian species. Observed yields are plotted
with standard errors at each of the four doses
considered.
half those expected in man at comparable
low doses.
Deletion data from the interspecific com-
parisons in the above experiments (6) sug-
gest that mouse and man are equally sensi-
tive to the production of that specific type
of genetic damage. Since it has been shown
that a significant proportion of the "spe-
cific-locus" mutations in the mouse are in-
deed minute deletions (16,17), it might be
argued that mouse and man are equally sen-
sitive to such genetic damage.
Interspecific comparisons on the produc-
tion of chromosomal aberrations by chemi-
cal mutagens are still meager. Some com-
ments can be made, however, on the basis
of data collected on different species in dif-
ferent laboratories. These comparisons
must be tempered with the precaution that
different species are very likely to metabo-
lize mutagens in different ways, thus creat-
ing the likelihood of diverse quantitative
responses. For example, in studies by Lega-
tor et al. (18) and Brewen et al. (13) on
the production of chromosome aberrations
in the bone marrow of the rat and Chinese
hamster, respectively, by cyclamate and its
metabolic byproducts, a significant level of
chromatid aberrations was found in the rat
after repeated doses of cyclamate and cy-
clohexylamine, whereas no effect was found
Environmental Health Perspectives 160in the comparable experiments done on the
Chinese hamster. Comparable findings for
the cytogenetic effects of mitomycin C on
rat bone marrow and mouse spermatogonial
cells have been published (19, 20).
The issue becomes even more clouded
when data derived from other possible
mutagens are compared. In some instances,
different laboratories obtain significantly
different results when the same experimen-
tal systems are used. This type of inconsis-
tency makes interspecific comparisons even
more difficult. Generally speaking, however,
it can be stated that when potent mutagens
are tested in various mammalian systems,
qualitatively if not quantitatively similar
results are obtained.
Comparisons of Aberration Production
in Somatic and Germ Cells
Since chromosome aberrations produced
in somatic cells in no way pose a genetic
hazard to subsequent generations and it is
the recoverable damage that is important
in a strict genetic sense, it is imperative that
we be able to translate data derived from
somatic cell studies to the situation in the
genetically important germ cells. On the ba-
sis of radiation studies, it is obvious that
the quantitative level of damage observed
in somatic cells is many times greater than
that observed in particular stages of sper-
matogenesis and ultimately recovered in the
F1 progeny of treated individuals. For ex-
ample, analysis of peripheral leukocytes
from a male mouse given 300 R of whole
body x-irradiation shows a yield of 31% di-
centrics (6). In theory, reciprocal translo-
cations should be produced with the same
frequency as dicentrics. In the absence of
data to the contrary, we assume that this
theory is correct. When spermatogonial
stem cells are irradiated with the same dose
and analyzed at diplotene-diakinesis of the
primary spermatocyte stage, the yield of re-
ciprocal translocations is only about 8%o.
This is only one-fourth the yield that would
have been predicted from the leukocyte
data. Ford et al. (21) found that aproxi-
mately one-eighth of the reciprocal translo-
cations scored in primary spermatocytes
are recovered in the subsequent F1. Thus
the leukocyte data should be corrected by a
factor of 1/32 to arrive at an estimate of ge-
netically recoverable translocation fre-
quency. Why is this so?
Obviously, translocation-bearing cells are
lost between the time of treatment (sper-
matogonia) and the time of cytological
analysis (primary spermatocytes). Several
suggestions have been offered (22-25) to
explain this loss: (1) "unstable" (asym-
metrical) chromosome aberrations that re-
sult in cell death might be present in the
same cell as a reciprocal translocation; (2)
populations of cells might be either radio-
resistant to killing and translocation pro-
duction or radiosensitive to both; and (3)
the reciprocal translocations themselves
might confer a selective disadvantage to the
cells. The first of these alternatives does not
adequately explain the low yield of trans-
locations recovered in primary spermato-
cytes. It has been established that aberra-
tions are distributed in a Poisson fashion
after moderate doses of x-irradiation (26).
Thus there exists a population of cells with
no "unstable" aberrations, and within this
population the reciprocal translocations
have a Poisson distribution, with a mean
yield equal to that of the entire population.
Hence, if it is assumed that every "unsta-
ble" aberration is cell-lethal, the surviving
fraction will still have a reciprocal translo-
cation yield equal to the original yield. Cel-
lular radioresistance to both killing and
translocation production, and reduced pro-
liferative capacity of translocation-bearing
cells, could conceivably reduce the ultimate
yield of recovered translocations, but we do
not think they can account for a fourfold
difference.
There are two other mechanisms that can
dramatically reduce the initial yield of re-
ciprocal translocations. For the sake of sim-
plicity let us consider only that class of
cells with no "unstable" aberrations and a
normal proliferative capacity. Reciprocal
translocations will be distributed between
December 1973 161these cells so that the numbers of cells with
0, 1, 2, . . ., etc. will be the terms of a Pois-
son for the induced mean yield. It has been
shown that approximately 10-20% of all
translocations are incomplete (27), i.e., an
acentric fragment is generated by failure
of one or more of the chromosome products
to rejoin completely. Since loss of large
pieces of genetic material is generally cell-
lethal (28,29), it is expected that this 10-
207%o of incomplete translocations will be
lost through cell death. Since the zero class
will not be affected, this will result in a
10-20%o reduction in the mean yield. Sec-
ond, all stages of the cell cycle exist in the
spermatogonial germ cells, and conse-
quently chromatid-type aberrations will be
formed. Chromatid reciprocal transloca-
tions will involve only two of the four
chromatid strands, and if random segrega-
tion occurs at the next mitotic division four
classes of daughter cells are expected to be
formed in equal frequency (Fig. 3). Of
these four classes one will be normal, one
will be a balanced translocation heterozy-
gote, and two will be duplication deficien-
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FIGURE 3. Segregation products of a symmetrical
chromatid interchange.
cies. Cells in the latter two classes will die;
consequently, for every chromatid recipro-
cal translocation that is formed only 0.25
are expected to be recovered. If a cell has
two chromatid reciprocal translocations in
it, the probability of recovering both of
them in a daughter cell will be 1:16, and the
probability of recovering at least one will
be 1:8.
It would appear that the low yield of reci-
procal translocations observed in primary
spermatocytes as opposed to the theoretical
yield produced by equal doses in somatic
cells can readily be explained by simple cell
and chromosome kinetics. The question
then arises as to whether these simple ex-
planations can account for some of the ap-
parently inexplicable results obtained with
chemical mutagens.
Several papers have reported a complete
lack of reciprocal translocations in primary
spermatocytes after treatment of sperma-
togonia *with known chemical mutagens
(30-32). These observations are highly un-
usual in light of the fact that the same
chemicals have been shown to produce
dominant lethals and reciprocal transloca-
tions when postmeiotic cells are treated
(33-36), and they are also known to pro-
duce chromosome aberrations in the bone
marrow and in spermatogonia. Since the
aberrations are produced in the spermato-
gonia, the obvious question is why they are
never recovered in the primary spermato-
cytes. In addition, we also must ask, "How
meaningful are tests for chromosome aber-
ration production in bone marrow and sper-
matogonia by chemicals if the damage is
never realized in subsequent generations?"
Most of the chemicals tested to this point
are very specific in their time and mode of
action (37). For the most part the chromo-
some aberrations are either only produced
in those cells that are replicating their
DNA or this stage of the cell cycle is much
more sensitive than the other stages. When
the chemical is administered and a time lag
of 12-24 hr ensues before cytological exam-
ination, it is next to impossible to identify
the stage of the cell cycle the cells were in
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tional experimental variable, e.g., tritiated
thymidine. Data that are presented as
"breaks per cell" then become essentially
meaningless, because they do not allow for
discrimination of the distribution of the
damage on an individual cell basis. Thus,
for example, if 200 randomly selected cells
are analyzed and the mean yield of ex-
changes is 0.5 per cell, there is no way to
determine whether 100 cells each had one
exchange or 50 cells each had two ex-
changes, or what. Furthermore, only the
symmetrical (reciprocal) exchanges are ex-
pected to survive, and if these are of the
chromatid variety, as is the case when they
are induced in the S phase, only a small por-
tion of those are expected to survive the
first mitotic division. This argument can be
demonstrated more accurately with a theo-
retical treatment of actual data.
Earlier in the present paper data were
presented on the production of chromatid
aberrations in human leukocytes by MMS.
One culture had been pulse-labeled with tri-
tiated thymidine and treated with MMS 18
hr before metaphase figures were collected.
A total of 168 figures were analyzed, and
113 chromatid interchanges were scored,
for a yield of 67%. However, when the cells
were checked for the presence of label it
was found that 91 labeled cells had 107
chromatid exchanges and 77 unlabeled cells
had 6 chromatid exchanges, corresponding
to yields of 118 and 8%, respectively. If
the aberrations in the labeled cells were dis-
tributed in a random fashion we would ex-
pect half of them to be cell-lethal, asym-
metrical types and half to be symmetrical
types. Thus the yield of symmetrical ex-
changes in the labeled cells would be approx-
imately 60%c and the proportion of cells
with 0, 1, 2, 3, ..., etc. exchanges would
be 0.5488, 0.3192, 0.0988, 0.0198, ..., etc.
The proportion of cells with the same num-
ber of asymmetrical exchanges would be the
same, and the relative frequencies of the
various combinations would be as shown
in Table 3. We have assumed that all asym-
metrical exchanges are lethal; thus, any cell
containing one will never propagate, and
we must contend only with those having
only symmetrical exchanges. Thus, if we
take a theoretical population of 1,000 scored
cells, approximately 50% of which were in
S at the time of the MMS treatment and
sustained chromosome damage at the level
of 120% chromatid interchanges, only
3.4% symmetrical exchanges would be ex-
pected to be seen in the subsequent primary
spermatocytes.
This figure is derived in the following
way. Half, or 500, of the 1000 cells would
have been unlabeled and practically void of
Table 3. Expected Poisson distributions of chromatid exchange classes based on a
mean yield of 60% symmetrical and 60% asymmetrical exchanges.
Asymmetrical a
0 1 2 3
Symmetrical 0.5488 0.3293 0.0988 0.0231
0 0.5488 0.3012 0.1807 0.0542 0.0127
(151) (90) (27) (6) 274
1 0.3293 0.1807 0.1084 0.0325 0.0076
(90) (54) (16) (4) 164
2 0.0988 0.0542 0.0325 0.0098 0.0023
(27) (16) (5) (1) 49
3 0.0231 0.0127 0.0076 0.0023 0.0005
(6) (4) (1) 11
274 164 49 11 498
a The numbers in parentheses correspond to the numbers of cells in each class from a total population of 500
cells. The totals do not add to 500 cells due to rounding off.
December 1973 163exchanges. The sum total of 600 exchanges
would have been in the labeled cells, and
we assume that half, or 300, of them would
have been asymmetrical and the other half
symmetrical. We then assume that the ex-
change classes are distributed in a random
fashion, so that the proportions of cells with
0, 1, 2, or 3 exchanges of each type are the
same as those given for the respective
classes in Table 3. The various proportions
are then multiplied to determine what frac-
tions would have zero asymmetrical ex-
changes and either 0, 1, 2, or 3 symmetrical
exchanges. When this is done it is seen that
of the original 500 cells that were labeled,
151 would have no exchanges, 90 would have
a single symmetrical exchange, 27 would
have two symmetrical exchanges, and 6
would have three symmetrical exchanges.
All the rest would have at least one asym-
metrical exchange and would be killed.
Next we assume that 20% of all the sym-
metrical exchanges are incomplete and cell
lethal. Thus the 90 singles would be reduced
to 72, the 27 doubles to 17 (27 x 0.8 x 0.8,
since both exchanges must be complete to
insure survival), and the six triples to three.
Next we correct for random segregation at
the first mitosis, and the new numbers of
exchange-bearing cells become: single = 21
(18 from the original singles plus 2 from
the original doubles plus approximately 1
from the original triples); double = 1; and
triple < 1. This adds up to a total of 23 ex-
changes in 672 cells (500 unlabeled, 150 la-
beled zero class, 21 single class, 1 double).
Thus the original yield of 60% chromatid
exchanges observed in treated spermato-
gonia is expected to yield only 3.4%o recipro-
cal translocations in the primary spermato-
cytes. The yield of 3.4%o estimated in this
example will, of course, vary if the values
for labeling index or the proportion of in-
completeness differ from those used here.
These calculations do not take into account
possible selective disadvantages caused by
the translocation once it survives the first
mitotic division. These could conceivably re-
duce the recovered yield even more. It is
reasonably obvious from these calculations
that restraint should be used in estimating
genetic hazards from chromatid aberration
yields in bone marrow and spermatogonia.
We hasten to add that our considerations
are theoretical in nature, and that they
should be tested by an experiment designed
to enable the parameters used in the fore-
going example to be determined. In this
way, the proportion of reciprocal transloca-
tions expected to be found in primary sper-
matocytes from a known yield observed in
spermatogonia could be compared with the
actual number observed in spermatocytes
after treatment of spermatogonia. The
aberrations should be classified so that the
frequencies of symmetrical and asymmetri-
cal interchanges would be known; the pro-
portion of incomplete interchanges should
also be recorded; and the labeling indexes
as well as the frequencies of aberrations in
labeled and unlabeled cells should also be
obtained. Such information would enable us
to offer some explanation for the observa-
tion that certain chemicals induce chroma-
tid aberrations in spermatogonial cells but
none are recovered in primary spermato-
cytes, and it should also provide a basis for
evaluating the possible genetic hazard from
chemicals.
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